International Trade Commission April 12, 2010 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
In the Matter of Certain Non-Shellfish Derived Glucosamine and Products Containing Same; Notice of Commission Determination To Affirm an Initial Determination Granting a Joint Motion To Terminate The Investigation as to Respondent Ethical Naturals, Inc. From the Investigation Based Upon a Settlement Agreement; Termination of Investigation
Notice is hereby given that the U.S. International Trade Commission has determined to affirm an initial determination (``ID'') (Order No. 26) granting a joint motion to terminate the investigation as to respondent Ethical Naturals, Inc. from the investigation based upon a settlement agreement. The investigation is terminated.
In the Matter of Certain Products and Pharmaceutical Compositions Containing Recombinant Human Erythropoietin;
Notice is hereby given that the U.S. International Trade Commission has determined to grant Amgen Inc.'s motion for partial termination of the above-referenced investigation and that the Commission is requesting briefing on issues relating to summary determination and to remedy, the public interest, and bonding.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
